1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1 of 4
FEATURED COMPANIES
- AbbVie
- Bausch Health
- Novartis
- Pfizer
- MORE
About this market
The technological advances in drug delivery to push growth in the market. The increasing need for novel drug delivery systems has led to the advent of intravitreal implants, which are small hair-stranded sized devices that are implanted into the middle layer of the eye. The analysts have predicted that the ocular inflammation treatment market will register a CAGR of more than 6% by 2023.
Market Overview
Growing awareness of eye care
Several organizations are conducting awareness campaigns on various eye-related diseases. Thus, the rising awareness about eye related diseases, including ocular inflammation is expected to contribute to the market growth during the forecast period.
Growing preference for surgeries
The global ocular inflammation market poses high threat from alternative treatment options such as non-invasive surgeries such as LASER treatments and invasive surgeries such as vitrectomy.
For the detailed list of factors that will drive and challenge the growth of the ocular inflammation treatment market during the 2019-2023, view the full report.
Competitive Landscape
The market appears to be concentrated and with the presence of several companies including AbbVie and Bausch Health, the competitive environment is quite intense. Factors such as the growing awareness of eye care and the technological advances in drug delivery, will provide considerable growth opportunities to ocular inflammation treatment manufactures. AbbVie, Bausch Health, Novartis, and Pfizer are some of the major companies covered in this report.
The technological advances in drug delivery to push growth in the market. The increasing need for novel drug delivery systems has led to the advent of intravitreal implants, which are small hair-stranded sized devices that are implanted into the middle layer of the eye. The analysts have predicted that the ocular inflammation treatment market will register a CAGR of more than 6% by 2023.
Market Overview
Growing awareness of eye care
Several organizations are conducting awareness campaigns on various eye-related diseases. Thus, the rising awareness about eye related diseases, including ocular inflammation is expected to contribute to the market growth during the forecast period.
Growing preference for surgeries
The global ocular inflammation market poses high threat from alternative treatment options such as non-invasive surgeries such as LASER treatments and invasive surgeries such as vitrectomy.
For the detailed list of factors that will drive and challenge the growth of the ocular inflammation treatment market during the 2019-2023, view the full report.
Competitive Landscape
The market appears to be concentrated and with the presence of several companies including AbbVie and Bausch Health, the competitive environment is quite intense. Factors such as the growing awareness of eye care and the technological advances in drug delivery, will provide considerable growth opportunities to ocular inflammation treatment manufactures. AbbVie, Bausch Health, Novartis, and Pfizer are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4
FEATURED COMPANIES
- AbbVie
- Bausch Health
- Novartis
- Pfizer
- MORE
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 09: GEOGRAPHIC LANDSCAPE
PART 11: DRIVERS AND CHALLENGES
PART 13: VENDOR LANDSCAPE
Exhibit 01: Global ophthalmology drugs market
Exhibit 02: Segments of global ophthalmology drugs market
Exhibit 03: Global ocular inflammation treatment market: An overview
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Corticosteroids - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Corticosteroids - Year-over-year growth 2019-2023 (%)
Exhibit 22: Immunosuppressants - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Immunosuppressants - Year-over-year growth 2019-2023 (%)
Exhibit 24: Anti-infectives - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Anti-infectives - Year-over-year growth 2019-2023 (%)
Exhibit 26: Other drug classes - Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Other drug classes - Year-over-year growth 2019-2023 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Global ocular inflammation treatment market: Segmentation based on RoA
Exhibit 30: Market overview of global topical ocular inflammation treatment market
Exhibit 31: Market overview of global parenteral ocular inflammation treatment market
Exhibit 32: Market overview of global oral ocular inflammation treatment market
Exhibit 33: Customer landscape
Exhibit 34: Market share by geography 2018-2023 (%)
Exhibit 35: Geographic comparison
Exhibit 36: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 38: EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 40: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 41: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Global prevalence of geriatric population
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Vendor landscape
Exhibit 47: Landscape disruption
Exhibit 48: Vendors covered
Exhibit 49: Vendor classification
Exhibit 50: Market positioning of vendors
Exhibit 51: AbbVie - Vendor overview
Exhibit 52: AbbVie - Business segments
Exhibit 53: AbbVie - Organizational developments
Exhibit 54: AbbVie - Geographic focus
Exhibit 55: AbbVie - Key offerings
Exhibit 56: AbbVie - Key customers
Exhibit 57: ALLERGAN - Vendor overview
Exhibit 58: ALLERGAN - Business segments
Exhibit 59: ALLERGAN - Organizational developments
Exhibit 60: ALLERGAN - Geographic focus
Exhibit 61: ALLERGAN - Segment focus
Exhibit 62: ALLERGAN - Key offerings
Exhibit 63: ALLERGAN - Key customers
Exhibit 64: Bausch Health - Vendor overview
Exhibit 65: Bausch Health - Business segments
Exhibit 66: Bausch Health - Organizational developments
Exhibit 67: Bausch Health - Geographic focus
Exhibit 68: Bausch Health - Segment focus
Exhibit 69: Bausch Health - Key offerings
Exhibit 70: Bausch Health - Key customers
Exhibit 71: Novartis - Vendor overview
Exhibit 72: Novartis - Business segments
Exhibit 73: Novartis - Organizational developments
Exhibit 74: Novartis - Geographic focus
Exhibit 75: Novartis - Segment focus
Exhibit 76: Novartis - Key offerings
Exhibit 77: Novartis - Key customers
Exhibit 78: Pfizer - Vendor overview
Exhibit 79: Pfizer - Business segments
Exhibit 80: Pfizer - Organizational developments
Exhibit 81: Pfizer - Geographic focus
Exhibit 82: Pfizer - Segment focus
Exhibit 83: Pfizer - Key offerings
Exhibit 84: Pfizer - Key customers
PART 02: SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segmentation by product
- Comparison by product
- Corticosteroids - Market size and forecast 2018-2023
- Immunosuppressants - Market size and forecast 2018-2023
- Anti-infectives - Market size and forecast 2018-2023
- Other drug classes - Market size and forecast 2018-2023
- Market opportunity by product
- Market segmentation by RoA
PART 09: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- Americas - Market size and forecast 2018-2023
- EMEA - Market size and forecast 2018-2023
- APAC - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Vendors covered
- Vendor classification
- Market positioning of vendors
- AbbVie
- ALLERGAN
- Bausch Health
- Novartis
- Pfizer
- Research methodology
- List of abbreviations
Exhibit 01: Global ophthalmology drugs market
Exhibit 02: Segments of global ophthalmology drugs market
Exhibit 03: Global ocular inflammation treatment market: An overview
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Corticosteroids - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Corticosteroids - Year-over-year growth 2019-2023 (%)
Exhibit 22: Immunosuppressants - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Immunosuppressants - Year-over-year growth 2019-2023 (%)
Exhibit 24: Anti-infectives - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Anti-infectives - Year-over-year growth 2019-2023 (%)
Exhibit 26: Other drug classes - Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Other drug classes - Year-over-year growth 2019-2023 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Global ocular inflammation treatment market: Segmentation based on RoA
Exhibit 30: Market overview of global topical ocular inflammation treatment market
Exhibit 31: Market overview of global parenteral ocular inflammation treatment market
Exhibit 32: Market overview of global oral ocular inflammation treatment market
Exhibit 33: Customer landscape
Exhibit 34: Market share by geography 2018-2023 (%)
Exhibit 35: Geographic comparison
Exhibit 36: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 38: EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 40: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 41: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Global prevalence of geriatric population
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Vendor landscape
Exhibit 47: Landscape disruption
Exhibit 48: Vendors covered
Exhibit 49: Vendor classification
Exhibit 50: Market positioning of vendors
Exhibit 51: AbbVie - Vendor overview
Exhibit 52: AbbVie - Business segments
Exhibit 53: AbbVie - Organizational developments
Exhibit 54: AbbVie - Geographic focus
Exhibit 55: AbbVie - Key offerings
Exhibit 56: AbbVie - Key customers
Exhibit 57: ALLERGAN - Vendor overview
Exhibit 58: ALLERGAN - Business segments
Exhibit 59: ALLERGAN - Organizational developments
Exhibit 60: ALLERGAN - Geographic focus
Exhibit 61: ALLERGAN - Segment focus
Exhibit 62: ALLERGAN - Key offerings
Exhibit 63: ALLERGAN - Key customers
Exhibit 64: Bausch Health - Vendor overview
Exhibit 65: Bausch Health - Business segments
Exhibit 66: Bausch Health - Organizational developments
Exhibit 67: Bausch Health - Geographic focus
Exhibit 68: Bausch Health - Segment focus
Exhibit 69: Bausch Health - Key offerings
Exhibit 70: Bausch Health - Key customers
Exhibit 71: Novartis - Vendor overview
Exhibit 72: Novartis - Business segments
Exhibit 73: Novartis - Organizational developments
Exhibit 74: Novartis - Geographic focus
Exhibit 75: Novartis - Segment focus
Exhibit 76: Novartis - Key offerings
Exhibit 77: Novartis - Key customers
Exhibit 78: Pfizer - Vendor overview
Exhibit 79: Pfizer - Business segments
Exhibit 80: Pfizer - Organizational developments
Exhibit 81: Pfizer - Geographic focus
Exhibit 82: Pfizer - Segment focus
Exhibit 83: Pfizer - Key offerings
Exhibit 84: Pfizer - Key customers
Note: Product cover images may vary from those shown
3 of 4
LOADING...
4 of 4
FEATURED COMPANIES
- AbbVie
- Bausch Health
- Novartis
- Pfizer
- MORE
Global Ocular Inflammation Treatment Market 2019-2023
The author of the report recognizes the following companies as the key players in the global ocular inflammation treatment market: AbbVie, Bausch Health, Novartis, and Pfizer.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the technological advances in drug delivery.”
According to the report, one of the major drivers for this market is the growing awareness of eye care.
Further, the report states that one of the major factors hindering the growth of this market is the growing preference for surgeries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The author of the report recognizes the following companies as the key players in the global ocular inflammation treatment market: AbbVie, Bausch Health, Novartis, and Pfizer.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the technological advances in drug delivery.”
According to the report, one of the major drivers for this market is the growing awareness of eye care.
Further, the report states that one of the major factors hindering the growth of this market is the growing preference for surgeries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
- AbbVie
- Bausch Health
- Novartis
- Pfizer
Note: Product cover images may vary from those shown
